CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans
暂无分享,去创建一个
K. Ohashi | T. Ishizaki | T. Furuta | K. Kosuge | H. Hanai | M. Kimura | M. Nishimoto | E. Kaneko | M. Takashima | Xue-Jun Zhao | Xue‐Jun Zhao
[1] K. McColl,et al. Eradication of Helicobacter pylori: an objective assessment of current therapies. , 1997, British journal of clinical pharmacology.
[2] Kyoichi Ohashi,et al. Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer , 1998, Annals of Internal Medicine.
[3] M. Blaser,et al. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. , 1997, Gastroenterology.
[4] T. Furuta,et al. Study of transmission routes of Helicobacter pylori in relation to seroprevalence of hepatitis A virus , 1997, Journal of clinical microbiology.
[5] J. Goldstein,et al. Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. , 1997, The Journal of pharmacology and experimental therapeutics.
[6] L. Bertilsson,et al. CYP2C19 genotype and phenotype determined by omeprazole in a Korean population. , 1996, Pharmacogenetics.
[7] T Ishizaki,et al. Genotyping of S‐mephenytoin 4′‐hydroxylation in an extended Japanese population , 1996, Clinical pharmacology and therapeutics.
[8] J. Balian,et al. Determination of CYP2C19 phenotype in black Americans with omeprazole: Correlation with genotype , 1996, Clinical pharmacology and therapeutics.
[9] R. Spiller,et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice. , 1996, Gastroenterology.
[10] S. Higuchi,et al. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects , 1996 .
[11] A. D. Rodrigues,et al. Identification of the human P450 enzymes involved in lansoprazole metabolism. , 1996, The Journal of pharmacology and experimental therapeutics.
[12] R. Hopkins,et al. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. , 1996, Gastroenterology.
[13] A. Blum,et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. , 1996, Gastroenterology.
[14] L. Bertilsson,et al. Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. , 1995, Pharmacogenetics.
[15] J. Walsh,et al. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. , 1995, The New England journal of medicine.
[16] A. Blum,et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. , 1995, Gut.
[17] L. Pickle,et al. The hydroxylation of omeprazole correlates with S‐mephenytoin metabolism: A population study , 1995, Clinical pharmacology and therapeutics.
[18] M. Ingelman-Sundberg,et al. Phenotyping and genotyping of S‐mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe , 1995, Clinical pharmacology and therapeutics.
[19] L. Bertilsson,et al. Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19. , 1995, British journal of clinical pharmacology.
[20] S. Miehlke,et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. , 1995, Gastroenterology.
[21] J. Launay,et al. Helicobacter pylori infection: Physiopathologic implication of Nα-methyl histamine , 1995 .
[22] X. Fan,et al. Increased gastric production of interleukin-8 and tumour necrosis factor in patients with Helicobacter pylori infection. , 1995, Journal of clinical pathology.
[23] Y. Matsuzawa,et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. , 1994, The American journal of physiology.
[24] G R Wilkinson,et al. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. , 1994, Molecular pharmacology.
[25] J. Jansen,et al. Basal serum gastrin concentrations before and after eradication elicobacter pylori infection measured by sequence specific radioimmunoassays , 1994, Alimentary pharmacology & therapeutics.
[26] K. Sewing,et al. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase. , 1994, Gut.
[27] M. Wolfe,et al. The effect of recombinant cytokines on [14C]-aminopyrine accumulation by isolated canine parietal cells. , 1994, The Journal of pharmacology and experimental therapeutics.
[28] G. Strohmeyer,et al. Effects of Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells. , 1994, Gut.
[29] J. Miners,et al. Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. , 1994, British journal of clinical pharmacology.
[30] S. V. van Deventer,et al. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. , 1994, Scandinavian journal of gastroenterology.
[31] T. Andersson,et al. Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals. , 1994, Therapeutic drug monitoring.
[32] R. Koehler,et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. , 1994, Gastroenterology.
[33] T. Kamataki,et al. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. , 1993, The Journal of pharmacology and experimental therapeutics.
[34] Kaoru Kobayashi,et al. Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 column. , 1992, Journal of chromatography.
[35] K. Chiba,et al. Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population. , 1992, The Journal of pharmacology and experimental therapeutics.
[36] J. Crabtree,et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. , 1991, Gut.
[37] D. Graham,et al. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. , 1991, Gastroenterology.
[38] M. Quina,et al. Omeprazole in the treatment of peptic ulcers resistant to H2‐receptor antagonist , 1990, Alimentary pharmacology & therapeutics.
[39] T. Ishizaki,et al. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese , 1989, Clinical pharmacology and therapeutics.
[40] S. Brand,et al. Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. , 1988, The Journal of clinical investigation.
[41] R. Branch,et al. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations , 1985, Clinical pharmacology and therapeutics.
[42] W. Irvine,et al. Radioimmunoassay of plasmagastrin in pernicious anaemia, achlorhydria without pernicious anaemia, hypochlorhydria, and in controls. , 1971, Lancet.
[43] M. Kajimura,et al. Effect of Helicobacter pylori infection on gastric juice pH. , 1998, Scandinavian journal of gastroenterology.
[44] M. Classen,et al. Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. , 1996, Gastroenterology.
[45] G. Sachs,et al. The pharmacology of the gastric acid pump: the H+,K+ ATPase. , 1995, Annual review of pharmacology and toxicology.
[46] G. Sachs,et al. The gastric H+,K+-ATPase: the site of action of omeprazole. , 1989, Scandinavian journal of gastroenterology. Supplement.
[47] P. Brandtzaeg,et al. Immunohistochemical investigation of gastrin-producing cells (G cells).The distribution of g cells in resected human stomachs. , 1976, Scandinavian journal of gastroenterology.